Related Experiment Video
Updated: Feb 23, 2026

Culture of Neurospheres Derived from the Neurogenic Niches in Adult Prairie Voles
Published on: June 10, 2020
Oxytocin and Schizophrenia Spectrum Disorders
Ulrich Ettinger1, René Hurlemann2, Raymond C K Chan3,4
1Department of Psychology, University of Bonn, Bonn, Germany. ulrich.ettinger@uni-bonn.de.
Oxytocin (OXT) shows inconsistent effects for treating schizophrenia symptoms and social cognition deficits. Further research is needed to explore its potential in schizophrenia spectrum disorders.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Schizophrenia treatment faces unmet needs, particularly for negative symptoms and social cognitive deficits.
- Oxytocin (OXT) is being investigated as a potential therapeutic agent for these impairments.
Purpose of the Study:
- To review existing studies on oxytocin's effects in schizophrenia and related spectrum disorders.
- To evaluate OXT's impact on clinical symptoms, social cognition, and brain function in schizophrenia patients.
Main Methods:
- Systematic review of studies investigating oxytocin in schizophrenia.
- Analysis of clinical, neuropsychological, and functional magnetic resonance imaging (fMRI) data.
- Inclusion of studies on subclinical schizophrenia spectrum samples, including those with schizotypal personality traits.
Main Results:
- Evidence for the beneficial effects of oxytocin in schizophrenia is currently inconsistent.
- Further investigation is required to clarify OXT's therapeutic role.
Conclusions:
- Oxytocin's efficacy in treating schizophrenia symptoms and social cognitive deficits remains uncertain.
- More research is necessary, particularly within the schizophrenia spectrum, to determine optimal therapeutic strategies.
More Related Videos
09:12Assessing Cellular Stress and Inflammation in Discrete Oxytocin-secreting Brain Nuclei in the Neonatal Rat Before and After First Colostrum Feeding
Published on: November 14, 2018
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Neurotransmitters
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychological and Sociocultural Causes of Schizophrenia
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy